Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Russian drones, missiles strike Ukraine killing 11, wounding over 100
Gunman kills six family members in eastern Iowa, police say
Trump says no Israeli troops will go to Beirut after call with Netanyahu
Moderna and other groups get $60 million to develop Ebola vaccine
Bus driver charged with five counts of manslaughter in Virginia highway wreck
